108 related articles for article (PubMed ID: 23073167)
1. 1p19q co-deleted oligodendroglioma metastatic to bone.
Greene J; Cadoo K; Ti J; O'Donnell N; Allcutt D; Farrell M; Grogan L
Clin Neuropathol; 2013; 32(2):139-41. PubMed ID: 23073167
[No Abstract] [Full Text] [Related]
2. 1p/19q chromosome deletions in metastatic oligodendroglioma.
Merrell R; Nabors LB; Perry A; Palmer CA
J Neurooncol; 2006 Nov; 80(2):203-7. PubMed ID: 16710746
[TBL] [Abstract][Full Text] [Related]
3. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
[TBL] [Abstract][Full Text] [Related]
4. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic study of a metastatic oligodendroglioma.
Giordana MT; Ghimenti C; Leonardo E; Balteri I; Iudicello M; Duò D
J Neurooncol; 2004 Feb; 66(3):265-71. PubMed ID: 15015656
[TBL] [Abstract][Full Text] [Related]
6. Oligodendroglioma with neurocytic differentiation and characteristic loss of heterozygosity on chromosomes 1p and 19q.
Vajtai I; Arnold M; Vassella E
Acta Neuropathol; 2005 Nov; 110(5):520-2. PubMed ID: 16222523
[No Abstract] [Full Text] [Related]
7. Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas.
Figarella-Branger D; Mokhtari K; Dehais C; Carpentier C; Colin C; Jouvet A; Uro-Coste E; Forest F; Maurage CA; Vignaud JM; Polivka M; Lechapt-Zalcman E; Eimer S; Viennet G; Quintin-Roué I; Aubriot-Lorton MH; Diebold MD; Loussouarn D; Lacroix C; Rigau V; Laquerrière A; Vandenbos F; Michalak S; Sevestre H; Peoch M; Labrousse F; Christov C; Kemeny JL; Chenard MP; Chiforeanu D; Ducray F; Idbaih A; Delattre JY;
Neuro Oncol; 2016 Jun; 18(6):888-90. PubMed ID: 27175000
[No Abstract] [Full Text] [Related]
8. Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.
Demeulenaere M; Duerinck J; DU Four S; Fostier K; Michotte A; Neyns B
Anticancer Res; 2016 Aug; 36(8):4145-9. PubMed ID: 27466523
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration cytology of metastatic oligodendroglioma: case report and literature review.
Can B; Akpolat I; Meydan D; Üner A; Kandemir B; Söylemezoğlu F
Acta Cytol; 2012; 56(1):97-103. PubMed ID: 22236753
[TBL] [Abstract][Full Text] [Related]
10. Extracranial metastasis of anaplastic oligodendroglioma with 1p19q loss of heterozygosity--case report.
Noshita N; Mashiyama S; Fukawa O; Asano S; Watanabe M; Tominaga T
Neurol Med Chir (Tokyo); 2010; 50(2):161-4. PubMed ID: 20185886
[TBL] [Abstract][Full Text] [Related]
11. MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status.
Sherman JH; Prevedello DM; Shah L; Raghavan P; Pouratian N; Starke RM; Lopes MB; Shaffrey ME; Schiff D
Acta Neurochir (Wien); 2010 Nov; 152(11):1827-34. PubMed ID: 20711790
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
Burgy M; Chenard MP; Noël G; Bourahla K; Schott R
J Med Case Rep; 2019 Jun; 13(1):202. PubMed ID: 31248444
[TBL] [Abstract][Full Text] [Related]
13. [Brain oligodendroglial tumors].
Iuchi T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():110-5. PubMed ID: 16201509
[No Abstract] [Full Text] [Related]
14. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation.
Pinkham MB; Telford N; Whitfield GA; Colaco RJ; O'Neill F; McBain CA
Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):445-53. PubMed ID: 25971646
[TBL] [Abstract][Full Text] [Related]
15. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.
Sonabend AM; Lesniak MS
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S25-32. PubMed ID: 16274268
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma.
Blough MD; Al-Najjar M; Chesnelong C; Binding CE; Rogers AD; Luchman HA; Kelly JJ; Fliegel L; Morozova O; Yip S; Marra M; Weiss S; Chan JA; Cairncross JG
Ann Neurol; 2012 Jun; 71(6):845-9. PubMed ID: 22718548
[TBL] [Abstract][Full Text] [Related]
18. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG
Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal dissemination of a pediatric neoplasm with 1p19q deletion showing mixed immunohistochemical features of an oligodendroglioma and neurocytoma.
Rhiew RB; Manjila S; Lozen A; Guthikonda M; Sood S; Kupsky WJ
Acta Neurochir (Wien); 2010 Aug; 152(8):1425-9. PubMed ID: 20446099
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
